Artificial endocrine gland containing hormone-producing cells

Claim 2

An implantable device for supplying a hormone to a patient comprising: (a) a housing constituted by a sack and a hollow stem; the sack having at least one access opening and being constructed of a membrane compatible with body tissue and permeable to body fluid; the hollow stem having a distal end defining an extracorporeal segment and a proximal end defining a subcutaneous segment, the stem being compatible with body tissue and impermeable to body fluids; the sack access opening being sealingly coupled with the proximal end of the stem and together with the stem defining an access passageway to the sack; (b) a replaceable envelope containing live hormone-producing cells, the envelope being permeable to nutrients and a hormone; the envelope being removably located within the sack and adapted to pass through the stem; and (c) seal means for the access passageway.

Claim 3

The implantable device of claim 1 wherein the sack is constructed of material having a pore size small enough to prevent the passage of bacteria.

Claim 4

The device of claim 1 wherein the membrane sack is constructed of a membrane-like filter material.

Claim 5

The implantable device of claim 1 wherein the replaceable envelope is constructed of membrane-like filter material.

Claim 6

The implantable device of claim 1 including at least one porous cuff surrounding a portion of the subcutaneous segment of the hollow stem.

Claim 7

The implantable device of claim 1 wherein the replaceable envelope includes a withdrawal tab.

Claim 8

The implantable device of claim 1 including a connection means linking the replaceable envelope to the seal means.

Claim 9

The implantable device of claim 1 including a nutrient liquid placed within the housing.

Claim 10

The implantable device of claim 1 wherein the replaceable envelope has a toroidal configuration.

Claim 11

The implantable device of claim 1 wherein the hormone-producing cells are disposed within the replaceable envelope in a substantially unicellular layer.

Claim 12

The implantable device of claim 1 wherein the replaceable envelope includes live hormone-producing cells sandwiched between two layers of membrane.

Claim 13

The implantable device in accordance with claim 11 wherein the membrane envelope is a flexible collar.

Claim 14

The implantable device of claim 1 including an open polyethylene mesh on the exterior surface of the sack to add strength and resistance to breakage.

Claim 15

The implantable device of claim 1 including a second stem having a distal end defining an extracorporeal segment and a proximal end defining a subcutaneous segment, the second stem being compatible with body tissue and impermeable to body fluids, and wherein the sack has a tube-like shape having two access openings sealingly coupled with the proximal end of each stem to form a hose with each stem defining an access passageway to the sack.

Claim 16

An implantable device for supplying insulin to a patient comprising: (a) a housing constituted by a sack and a hollow stem; the sack having at least one access opening and being constructed of a semipermeable membrane compatible with body tissue and permeable to peritoneal fluid but substantially impermeable to bacteria; the hollow stem having a distal end defining an extracorporeal segment and a proximal end defining a subcutaneous segment, the stem being compatible with body tissue and impermeable to body fluids; the sack access opening being sealingly coupled with the proximal end of the stem and together with the stem defining an access passageway to the sack, the housing being adapted to be implanted in the patient with the extracorporeal segment extending outside the body of the patient; (b) a replaceable semipermeable membrane envelope containing live pancreatic islet cells, the envelope membrane being permeable to nutrients and insulin but impermeable to the pancreatic cells; the envelope being removeably located within the sack and adapted to pass through the stem; and (c) a plug to seal the distal end of the stem.

Claim 17

An implantable device for supplying insulin to a patient comprising: (a) a housing constituted by a sack and a hollow stem; the sack having at least one access opening and being constructed of a semipermeable membrane compatible with body tissue and permeable to peritoneal fluid but substantially impermeable to bacteria; the hollow stem having a distal end defining an extracorporeal segment and a proximal end defining a subcutaneous segment, the stem being compatible with body tissue and impermeable to body fluids; the sack access opening being sealingly coupled with the proximal end of the stem and together with the stem defining an access passageway to the sack, the housing being adapted to be implanted in the patient with the extracorporeal segment extending outside the body of the patient; (b) a replaceable semipermeable membrane envelope containing live pancreatic islet cells, the envelope membrane being permeable to nutrients and insulin but impermeable to the pancreatic cells; the envelope being removeably located within the sack and adapted to pass through the stem; and (c) a plug to seal the distal end of the stem.

Claim 18

The implantable device of claim 15 including at least one porous cuff surrounding a portion of the subcutaneous segment of the hollow stem.

Claim 19

The implantable device of claim 15 wherein the live pancreatic islet cells are disposed in a substantially unicellular layer sandwiched between two layers of membrane to form a flexible collar.

Claim 20

The implantable device in accordance with claim 17 including means for collapsing the collar to facilitate removal through the stem.

Claim 21

The implantable device of claim 15 wherein the extracorporeal segment includes a flexible zone comprising a plurality of circumferential grooves.

Claim 22

The implantable device of claim 15 wherein a plurality of replaceable envelopes are located within the sack.

Claim 23

The implantable device of claim 15 wherein the sack has a membrane with an effective pore size of about 0.025 to about 0.5 microns.

Claim 24

The implantable device of claim 15 wherein the replaceable envelope has a membrane with an effective pore size of no more than about 50 angstroms.

Claim 25

The implantable device of claim 15 including an open polyethylene mesh on the exterior surface of the sack to add strength and resistance to breakage.

Claim 26

An implantable device for supplying hormones to a patient comprising: (a) a hose constituted by a tube and two hollow stems; the tube having two open ends and being constructed of a membrane compatible with body tissue and permeable to body fluids; each stem having a distal end defining an extracorporeal segment and a proximal end defining a subcutaneous segment, each stem being compatible with body tissue and impermeable to body fluids; each end of the tube sealingly coupled with the proximal end of each stem such that each stem defines an access passageway to the tube; (b) a replaceable envelope containing live hormone-producing cells, the envelope being permeable to nutrients and a hormone; the envelope being removeably located within the sack and adapted to pass through either stem; and (c) seal means for each access passageway.

Claim 27

An implantable device for supplying hormones to a patient comprising: (a) a hose constituted by a tube and two hollow stems; the tube having two open ends and being constructed of a membrane compatible with body tissue and permeable to body fluids; each stem having a distal end defining an extracorporeal segment and a proximal end defining a subcutaneous segment, each stem being compatible with body tissue and impermeable to body fluids; each end of the tube sealingly coupled with the proximal end of each stem such that each stem defines an access passageway to the tube; (b) a replaceable envelope containing live hormone-producing cells, the envelope being permeable to nutrients and a hormone; the envelope being removeably located within the sack and adapted to pass through either stem; and (c) seal means for each access passageway.

Claim 28

The implantable device of claim 24 wherein the tube is constructed of a semipermeable membrane impermeable to bacteria.

Claim 29

The implantable device of claim 24 including at least one porous cuff surrounding a portion of the subcutaneous segment of each hollow stem.

Claim 30

The implantable device of claim 24 wherein the hormone-producing cells are disposed in a substantially unicellular layer sandwiched between two layers of membrane to form an expandable collar.

Claim 31

The device of claim 24 wherein the hormone-producing cells comprise pancreatic islet cells.

Claim 32

The implantable device of claim 24 wherein the tube has a membrane with an effective pore size of about 0.025 to about 0.5 microns.

Claim 33

The implantable device of claim 24 wherein the replaceable envelope has a membrane with an effective pore size of no more than about 50 angstroms.

Claim 34

The implantable device of claim 24 including an open polyethylene mesh on the exterior surface of the sack to add strength and resistance to breakage.

Claim 37

The method of claim 32, wherein the membrane wall placed in the patient is of material having a pore size sufficient to prevent the passage of bacteria.

Claim 38

The method of claim 32 including placing a nutrient liquid in the housing.

Claim 39

The method of claim 32 wherein the envelope of hormone-producing cells placed into the housing contains live pancreatic islet cells.